Park Avenue Securities LLC Has $9.70 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Park Avenue Securities LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,591 shares of the medical equipment provider’s stock after purchasing an additional 3,867 shares during the quarter. Park Avenue Securities LLC’s holdings in Intuitive Surgical were worth $9,703,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC lifted its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the period. Union Bancaire Privee UBP SA acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $6,509,000. Triasima Portfolio Management inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $266,000. Conning Inc. lifted its holdings in Intuitive Surgical by 7.4% during the 4th quarter. Conning Inc. now owns 3,629 shares of the medical equipment provider’s stock worth $1,894,000 after purchasing an additional 249 shares during the last quarter. Finally, Vest Financial LLC lifted its holdings in Intuitive Surgical by 22.1% during the 4th quarter. Vest Financial LLC now owns 2,725 shares of the medical equipment provider’s stock worth $1,422,000 after purchasing an additional 493 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several recent analyst reports. Royal Bank of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Evercore ISI decreased their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $596.05.

Intuitive Surgical Stock Down 0.2%

NASDAQ ISRG opened at $557.08 on Friday. The company has a market capitalization of $199.67 billion, a price-to-earnings ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The stock’s 50-day simple moving average is $521.99 and its two-hundred day simple moving average is $539.24. Intuitive Surgical, Inc. has a twelve month low of $413.52 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This trade represents a 68.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 25,443 shares of company stock worth $12,692,195. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.